Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-000735

Options or other derivatives

  • COO, GENERAL COUNSEL &CORP SEC acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Belloff Neil S. · COO, GENERAL COUNSEL &CORP SEC

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-12 Grant or award : show line 1 in the form Stock Options +120,000 120,000 D
Loading xslF345X03/form4-02172021_030226.xml…